http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Serve Robotics to Present at Cantor Global Technology Conference
-
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
-
Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress
-
Krystal Biotech (KRYS) Receives Positive CHMP Opinion for VYJUVEK
-
Juniper Networks (JNPR) and IBM (IBM) to Simplify Enterprise Network Operations with Next Era of Gen AI innovation
-
Juniper and IBM to Simplify Enterprise Network Operations with Next Era of Gen AI innovation
-
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
-
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
-
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference
-
Romios Gold Exhibiting at PDAC 2025 and Invites Shareholders and Delegates to Re-Discover Romios at Booth 2717
-
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
-
PAR Technology Corporation Announces Fourth Quarter and Full Year 2024 Results
-
CoinW at Consensus HK 2025: Driving Innovation and Blockchain's Future
-
Appian To Participate in Upcoming Investor Conferences
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
-
Predictmedix AI Launches Advanced AI Health Stations to Target the US Market
-
Cheems Memecoin Surpasses 80,000 Holders, Solidifying Its Place as a Leading Meme Token on BNB Chain
-
LiveOne (Nasdaq: LVO) Surpasses 1 Million Subscribers, Including Tesla
-
AB to List on Bitget in the Innovation and Web3 Zone, Marking a Key Milestone in Global Ecosystem Expansion
-
Magnet Biomedicine Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Novel Molecular Glue Medicines
-
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
-
BitVM Accelerated: BOB launches BitVM bridge on public testnet, announces BitVM/acc working group with major institutional partners
-
LotusFlare Partners with MTN for Strategic Digital Initiatives in South Africa
-
Own. App and $CREATE Fund Launch Groundbreaking Token Challenge: 100 Million Tokens Up for Grabs
-
transcosmos creates immersive Roblox game to experience Singapore in partnership with HIS
-
ProSiebenSat.1 Extends Partnership with SES
-
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis
-
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
-
SQ, XYZ DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Block, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action -
-
FTAI IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages FTAI Aviation Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Act
-
BIOA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action - BIOA
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
-
JBD Officially Launches MicroLED Printhead Module, Driving Upgrades in the Printing Industry
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
-
IIPR DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Innovative Industrial Properties, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline i
-
ROSEN, A LEADING NATIONAL FIRM, Encourages ICON plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - ICLR
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Alarum Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALAR
-
ROSEN, A LEADING LAW FIRM, Encourages Grocery Outlet Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GO
-
ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapse
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Elastic N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ESTC
-
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
-
ROSEN, A LEADING LAW FIRM, Encourages Dave Inc. Investors to Inquire About Securities Class Action Investigation - DAVE
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
-
ROSEN, A LEADING LAW FIRM, Encourages Polestar Automotive Holding UK PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - PSNY
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGT
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IAS
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages ModivCare Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MODV
-
TOP RANKED ROSEN LAW FIRM Encourages TELUS International (Cda) Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TIXT
-
Canada watchdog probing X's use of personal data in AI models' training

